One Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Hold
9,298
0.01% 437
2026
Q1
$342K Buy
9,298
+664
+8% +$31.5K 0.01% 435
2025
Q4
$439K Buy
8,634
+1,466
+20% +$75K 0.01% 402
2025
Q3
$398K Sell
7,168
-205
-3% -$12K 0.01% 389
2025
Q2
$509K Sell
7,373
-72
-1% -$4.9K 0.02% 363
2025
Q1
$517K Buy
+7,445
New +$615K 0.02% 289
2024
Q4
Sell
-2,147
Closed -$256K 385
2024
Q3
$256K Sell
2,147
-110
-5% -$14.7K 0.01% 334
2024
Q2
$322K Sell
2,257
-27
-1% -$3.58K 0.01% 322
2024
Q1
$293K Buy
2,284
+150
+7% +$17.9K 0.01% 256
2023
Q4
$221K Sell
2,134
-96
-4% -$9.49K 0.01% 274
2023
Q3
$203K Buy
+2,230
New +$196K 0.01% 269
2023
Q2
Sell
-3,468
Closed -$276K 311
2023
Q1
$276K Buy
+3,468
New +$246K 0.01% 269
2014
Q4
Sell
-230
Closed -$5K 357
2014
Q3
$5K Buy
+230
New +$5.29K ﹤0.01% 485

Other funds holding NVO

One Capital Management's NVO Position: Q2 2026 in Review

One Capital Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 9,298 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #437.

One Capital Management first reported a position in NVO in Q3 2014 and has held it in 13 quarters since. The position peaked at $517K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • One Capital Management held 9,298 shares of Novo Nordisk worth $342K as of Q2 2026.
  • One Capital Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of One Capital Management's portfolio in Q2 2026, its #437 holding.
  • One Capital Management first reported a position in Novo Nordisk in Q3 2014 and has held it in 13 quarters since.
  • One Capital Management's Novo Nordisk position peaked at $517K in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.